Related Articles
IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion
Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation
PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I
Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma
High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer